Alex P. Hamilton - 19 Nov 2025 Form 4 Insider Report for MANGOCEUTICALS, INC. (MGRX)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
26 Nov 2025, 16:30:13 UTC
Prior SEC filing
12 Sep 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Alex P. Hamilton

Key filing fact

Alex P. Hamilton filed Form 4 for MANGOCEUTICALS, INC. (MGRX) on 26 Nov 2025.

Key facts

  • This page summarizes Alex P. Hamilton's Form 4 filing for MANGOCEUTICALS, INC. (MGRX).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 26 Nov 2025, 16:30.

Change

  • Previous filing in this sequence was filed on 12 Sep 2025.
  • Current net transaction value: -$152,875.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001970448 Primary reporting owner

Hamilton Alex P.

Relationship
Director
Address
C/O MANGOCEUTICALS, INC., 15110 N. DALLAS PARKWAY, SUITE 600, DALLAS
Signature
/s/ Alex P. Hamilton
Signature date
26 Nov 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MGRX transaction

Common Stock

Sale

Transaction value
$152,875
Shares
-125,000
Change %
-97%
Price
$1.22
Shares after
3,334
Date
19 Nov 2025
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This transaction was executed in multiple trades at prices ranging from $1.195 to $1.2465, inclusive. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .